Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Spreadsheets are powerful tools for investment planning. Discover how to utilize them to track and manage your investments efficiently.
20,347 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
When a company director sells millions after a sharp rally, it stirs worry. But insider activity is nuanced. This gui...
JPMorgan argues a bold AI productivity push—the moonshot to avoid trillion national debt—could avert a looming $39 tr...
The Treasury praises relief from Trump’s cuts for millions of seniors, but the Social Security trust fund is projecte...
When a top executive sells a large block of stock, investors want to know whether it signals trouble or simply person...
Before full retirement age, Social Security imposes an earnings cap that can slash benefits by about half for every d...
A lingering story can ride beside your finances like a 'ghost passenger seat: reality.' This article explores how nar...
A self-employed architect plans a four-bucket retirement strategy that shifts income across Roth, HSA, and pretax acc...
A political clash over Medicaid waivers that compensate family caregivers could redraw how millions support aging rel...
A bipartisan transparency push targets health disclosures and finances of aging lawmakers, signaling a receipt-check ...
A notable fund boosted its Hexcel stake to roughly 23% of its portfolio after a $7.5 million purchase, sending the st...
Apple and Intel are reportedly exploring a U.S.-based chip supply and manufacturing pact. The talks, if they advance,...